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Abstract 
Purpose: Patients with reduced muscle mass have a worse outcome, but muscle mass is difficult to quantify in the 
ICU. Urinary creatinine excretion (UCE) reflects muscle mass, but has not been studied in critically ill patients. We 
evaluated the relation of baseline UCE with short‑term and long‑term mortality in patients admitted to our ICU.
Methods: Patients who stayed ≥ 24 h in the ICU with UCE measured within 3 days of admission were included. We 
excluded patients who developed acute kidney injury stage 3 during the first week of ICU stay. As muscle mass is 
considerably higher in men than women, we used sex‑stratified UCE quintiles. We assessed the relation of UCE with 
both in‑hospital mortality and long‑term mortality.
Results: From 37,283 patients, 6151 patients with 11,198 UCE measurements were included. Mean UCE was 54% 
higher in males compared to females. In‑hospital mortality was 17%, while at 5‑year follow‑up, 1299 (25%) patients 
had died. After adjustment for age, sex, estimated glomerular filtration rate, body mass index, reason for admission 
and disease severity, patients in the lowest UCE quintile had an increased in‑hospital mortality compared to the 
patients in the highest UCE quintile (OR 2.56, 95% CI 1.96–3.34). For long‑term mortality, the highest risk was also 
observed for patients in the lowest UCE quintile (HR 2.32, 95% CI 1.89–2.85), independent of confounders.
Conclusions: In ICU patients without severe renal dysfunction, low urinary creatinine excretion is associated with 
short‑term and long‑term mortality, independent of age, sex, renal function and disease characteristics, underscoring 
the role of muscle mass as risk factor for mortality and UCE as relevant biomarker.
Keywords: Creatinine, Urinary creatinine excretion, Muscle mass, Muscle wasting, Sarcopenia, Glomerular filtration 
rate, In‑hospital mortality, Long‑term mortality
Introduction
Muscle mass is an important determinant of the ability 
of patients in the intensive care unit (ICU) to overcome 
their disease. Sarcopenia (i.e. loss of muscle and func-
tion) on ICU admission is an independent risk factor for 
morbidity and mortality in critically ill patients [1–3]. 
Although several physical and laboratory indicators of 
muscle mass have been used in various other patient 
groups [4, 5], muscle mass is difficult to quantify in ICU 
patients.
Creatinine is the stable end product of creatine. Most 
creatine is present in muscle and is converted at a 
steady rate to creatinine. Creatinine is released into the 
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circulation and is almost exclusively excreted in the urine 
[6]. In steady state conditions, urinary excretion will 
equal creatinine production, irrespective of the serum 
creatinine concentration. Therefore, measurement of uri-
nary creatinine excretion (UCE) in 24-h urine collections 
is a widely accepted method for muscle mass estima-
tion in stable outpatient populations [5, 7–9]. In healthy 
subjects [10] and in patients with wasting conditions or 
(chronic) renal failure [4, 8], UCE has been associated 
with long-term mortality.
UCE has not been evaluated in critically ill patients. In 
our ICU, 24-h urine is routinely and continuously col-
lected to measure UCE. We hypothesized that in criti-
cally ill patients baseline UCE, as a reflection of muscle 
mass, is related with mortality. We analyzed the relation 
of UCE with short-term and long-term mortality.
Materials and methods
Study setting, patient selection and outcome
In this retrospective observational cohort study, we 
analyzed laboratory measurements of all patients aged 
15  years and older who were admitted to our ICU in a 
university hospital between January 2002 and April 2016. 
Reason for ICU-admission, age, sex, height, weight and 
the acute physiology and chronic health evaluation score 
4 (APACHE-IV) [11] were recorded. We routinely collect 
24-h urine samples as part of standard care at our ICU to 
determine the measured creatinine clearance. From 00:00 
to 24:00 all urine is collected in a large disposable con-
tainer. Patients who were discharged within 24 h of ICU 
admission or for whom no 24-h urine samples were avail-
able in the first 3 days after admission (i.e. due to meas-
urement errors in the lab or incomplete 24-h collections) 
were excluded. Only 24-h urine samples collected in the 
first 3 days after ICU admission were analyzed. UCE was 
determined by multiplying the urinary creatinine con-
centration in the 24-h urine with the 24-h urinary vol-
ume. We did not use weight-adjusted daily UCE, as we do 
not routinely weigh our patients. The median UCE was 
calculated for each patient and used for further analy-
ses. Corresponding daily serum creatinine levels were 
also available. Acute kidney injury (AKI) was assessed 
for the first 7 days of ICU admission. Patients with acute 
kidney injury (AKI) stage 3 (i.e. increase of serum creati-
nine to > 300% from baseline, or ≥ 354 µmol/L (4 mg/dL) 
or requiring renal replacement therapy [12]) during the 
first 7 ICU days, were excluded because of their inabil-
ity to produce urine or the unreliability of UCE as RRT 
interferes with UCE interpretation. Since complete data 
on urine output were often not available, we only used 
the serum creatinine based criteria of the KDIGO AKI 
guideline. We stratified for sex to account for the consid-
erable difference in creatinine excretion resulting from 
differences in body weight and composition between 
men and women [13]. This study was approved by our 
hospital’s medical ethical committee and since it con-
cerned an analysis of anonymized laboratory and clinical 
data, all collected during standard clinical care, informed 
consent was not required (METc 2011/132).
Samples
Urinary and serum creatinine measurements were per-
formed in the hospital’s certified central laboratory. 
Serum creatine kinase activity (CK) measured at ICU day 
one was also recorded to assess a possible effect of rhab-
domyolysis on creatinine. We did not exclude patients 
with potential rhabdomyolysis. Potential rhabdomyolysis 
was defined as CK ≥ 1500  U/L. Cardiothoracic surgery 
patients were not included in this subgroup. Estimated 
glomerular filtration (eGFR) was calculated with the 
Chronic Kidney Disease Epidemiology Collaboration 
(CKD-EPI) formula [14] with serum creatinine, sex, and 
age as input variables. Body mass index (BMI) was cal-
culated as weight (kg)/height2 (m). In order to adjust for 
acute changes in renal clearance of creatinine we also cal-
culated the estimated creatinine production, as described 
in the supplementary material file (SMF). Likewise, in 
the SMF we compared weight-adjusted UCE, i.e. UCE/kg 
with UCE in the predictive models in patients with avail-
able baseline body weight measurements.
Outcome
In-hospital mortality was used as the short-term out-
come measure. We performed near-complete long-term 
follow-up to determine   survival status in patients for 
5 years after hospital discharge, as recorded in the hos-
pital database and in the municipal mortality registry by 
January 2018.
Statistical analysis
Patient characteristics were calculated according to sex-
stratified UCE quintiles. Data were expressed as mean 
and standard deviation (SD) when normally distributed 
or median and interquartile range (IQR) when skewed. A 
chi-square test for categorical variables and ANOVA for 
normally distributed continuous variables or a Kruskal–
Wallis test for skewed distributed continuous variables 
was performed to determine variances between patient 
Take‑home message: 
Low urinary creatinine excretion early after ICU admission is a strong 
independent predictor of both short‑term and long‑term mortality, 
underscoring a role of muscle mass as risk factor for mortality. UCE 
thus constitutes a simple, readily available and relevant prognostic 
biomarker for critically ill patients.
characteristics across UCE quintiles. Missing data were 
imputed via multiple imputation (see SMF).
To assess associations of UCE with short-term and 
long-term mortality respectively, multivariable logis-
tic regression and Cox proportional hazards regres-
sion analyses were performed. The proportional hazard 
assumption was verified by inspection of “log–log” plots 
and by introducing interactions with survival time. UCE 
was entered as a categorical variable (quintiles) and 
as a continuous variable (with OR/HR calculated per 
5  mmol/24  h UCE decrease). Analyses were first per-
formed in a crude model (model 1: adjusted for sex when 
UCE was entered as continuous variable). Further analy-
ses cumulatively included adjustment for age (model 2), 
eGFR (model 3), BMI (model 4) and reason of admission 
and severity of illness (model 5). For patients discharged 
alive from the hospital, long-term survival was assessed 
with Kaplan–Meier survival curves according to the sex-
stratified UCE quintiles and evaluated with the log-rank 
test. Patients who were lost to follow-up were censored 
at that particular time point. Splines were fit by a logis-
tic regression model and a Cox proportional hazards 
regression model based on restricted cubic splines and 
adjustments as used in model 5. In secondary analyses, 
we tested for potential interaction by sex, age, BSA, renal 
function, disease severity and reason of admission. We 
also performed separate analyses for patients who devel-
oped AKI and for patients who did not develop AKI. 
Additional subgroup analyses were performed when 
effect modification was observed or when differences in 
UCE were expected in patient subgroups. In sensitivity 
analyses, we investigated for potential bias introduced 
by imputation, by restricting the dataset to complete 
cases. As additional sensitivity analysis, we assessed the 
potential confounding effect of rhabdomyolysis on UCE. 
Serum CK was log-transformed to adjust for its strongly 
skewed distribution. The secondary and sensitivity anal-
yses as listed in the results and SMF were adjusted for 
potential confounders that were included in model 5. P 
values < 0.05 were considered significant. Data were ana-
lyzed with SPSS 23.0 (IBM Inc. 2016, New York, USA) 
and R. version 3.4.2 (R foundation for Statistical Comput-
ing, Vienna, Austria).
Results
Patient characteristics and outcome
Of a total of 37,283 patients, 6151 patients were included. 
We excluded 28,493 patients because of ICU admission 
with a duration shorter than 24  h or incomplete 24-h 
urine collection. Another 2572 patients were excluded 
because of AKI stage 3 within 7  days of ICU admis-
sion, and finally 67 patients were excluded because of 
missing serum creatinine levels. In the remaining 6151 
patients, a total of 11,198 24-h urine creatinine measure-
ments (i.e. 1.8 measurements per patient) were deter-
mined during the first 3 ICU days (Fig. 1). The baseline 
clinical characteristics of the included patients are sum-
marized in Table 1. Median age of the included patients 
was 62 (50–72) years and 62% were male. Median UCE 
(IQR) was 54% higher in men than women, i.e. 12.2 
(9.0–15.7) vs. 7.9 (6.0–10.1)  mmol/day (P < 0.001). The 
mean UCE was similar on ICU-days 1 and 3 (10.8 ± 5.2 
vs. 11.0 ± 5.1  mmol/day, P = 0.34). Median urinary vol-
ume was 1.5 L (1.01–2.2). Reason for admission differed 
Fig. 1 Flowchart of patients included into the analysis
between the quintiles of UCE, with the highest number 
of trauma patients in the highest UCE quintile.
The median ICU length of stay was 4.6 (2.5–9.7) days, 
with a total hospital stay of 17.9 (10.8–30.7)  days 
(Table  1). The median serum creatinine was 73 (57–
104)  µmol/L and 1709 patients (28%) developed AKI 
stage 1 or stage 2 in the first week of ICU stay. Serum 
creatinine decreased in the first 3 ICU days [day 1: 79 
(62–104), day 3: 73 (57–106)  µmol/L, P < 0.001]. Serum 
creatinine and incidence of AKI were inversely associated 
with UCE quintiles. Median eGFR was 92 (60–122) mL/
min and was positively associated with UCE quintiles. 
Median follow-up time was 3.7 (2.1–7.6)  years with a 
maximum of 16.1 years. A completeness of follow-up of 
85% was achieved (see Supplementary Methods, SMF).
UCE and short‑term mortality
Overall in-hospital mortality was 17%. In-hospital mor-
tality decreased for the sex-specific quintiles of UCE, 
from 31% in the first quintile to 9% in the fifth quintile 
Table 1 Patient characteristics and outcome parameters
a Urinary creatinine excretion quintiles based on separate quintile intervals for males and females in mmol per day
b Data missing for 1709 (28%) patients
c Data missing for 1176 (19%) patients
d Data missing for 1173 (19%) patients
UCE sex‑stratified  quintilesa P
Q1 Q2 Q3 Q4 Q5
♂ ≤ 8.25; ♀ ≤ 5.55 ♂ > 8.25–10.9; ♀ > 5.55–7.10 ♂ > 10.9–13.45; ♀ > 7.10–8.55 ♂ > 13.45–16.65; ♀ > 8.55–10.50 ♂ > 16.65; ♀ > 10.50
Included patients 1228 1237 1208 1240 1238
Male (%) 760 (62%) 770 (62%) 756 (63%) 764 (62%) 764 (62%) 0.987
Age, years 67 (56–76) 67 (58–76) 66 (56–73) 60 (48–69) 51 (38–61) < 0.001
Urinary creatinine 
excretion, mmol/24 h
5.3 ± 2.0 8.4 ± 1.7 10.6 ± 2.2 12.9 ± 2.8 17.2 ± 4.5 < 0.001
 Men 6.0 ± 1.9 9.7 ± 0.7 12.2 ± 0.7 15.0 ± 0.9 20.0 ± 3.1 < 0.001
 Female 4.0 ± 1.3 6.3 ± 0.5 7.8 ± 0.4 9.5 ± 0.6 12.8 ± 2.4 < 0.001
Reason for admission 
(%)
< 0.001
 Medical 173 (14%) 129 (10%) 126 (10%) 158 (13%) 153 (12%)
 Surgical
  Trauma 35 (3%) 48 (4%) 58 (5%) 117 (9%) 279 (23%)
  Abdominal/vas‑
cular
288 (23%) 297 (24%) 291 (24%) 315 (25%) 289 (23%)
  Transplantation 54 (4%) 66 (5%) 54 (4%) 51 (4%) 18 (2%)
  Neurosurgery 31 (3%) 32 (3%) 41 (3%) 59 (5%) 86 (7%)
  Cardiothoracic 243 (20%) 319 (26%) 347 (29%) 286 (23%) 193 (16%)
 Miscellaneous 408 (33%) 346 (28%) 291 (24%) 254 (21%) 220 (18%)
ICU LOS, days 4.8 (2.6–10.1) 4.9 (2.7–10.1) 4.1 (2.3–8.7) 4.3 (2.3–9.6) 4.5 (2.5–9.8) 0.004
Hospital LOS, days 18.1 (9.2–34.7) 20.2 (12.1–34.2) 17.4 (11.2–30.0) 16.9 (10.3–28.2) 16.8 (10.2–28.7) < 0.001
APACHE‑IVb 73 ± 27 67 ± 24 64 ± 24 58 ± 24 53 ± 23 < 0.001
Length,  cmc 171 ± 10 173 ± 9 174 ± 9 176 ± 9 178 ± 9 < 0.001
Weight,  kgd 73 ± 16 75 ± 14 80 ± 15 83 ± 15 90 ± 18 < 0.001
BMIc 25 ± 5 25 ± 4 26 ± 4 27 ± 5 28 ± 6 < 0.001
BSA,  m2 c 1.8 ± 0.2 1.9 ± 0.2 2.0 ± 0.2 2.0 ± 0.2 2.1 ± 0.2 < 0.001
Acute kidney injury 539 (44%) 414 (34%) 305 (25%) 233 (19%) 218 (18%) < 0.001
 Stage 1 353 (65%) 301 (73%) 229 (75%) 173 (79%) 163 (64%)
 Stage 2 186 (35%) 113 (27%) 76 (25%) 60 (27%) 55 (25%)
Serum creatinine, 
µmol/L
86 (56–136) 76 (58–115) 73 (58–100) 70 (58–93) 69 (58–87) < 0.001
eGFR (mL/min/1.73m2) 72 (40–102) 82 (51–100) 87 (61–101) 93 (69–107) 100 (81–114) < 0.001
(P < 0.001, Fig.  2a). In multivariable logistic regression 
analyses with sex-specific quintiles of UCE, there was a 
2.4 times increased risk of in-hospital mortality in the 
lowest sex-specific UCE quintile compared to high-
est quintile (OR 2.56, 95% CI 1.96–3.34, P < 0.001), 
independent of potential confounders (Table  2, model 
5). In multivariable logistic regression analyses, with 
adjustment for sex, UCE expressed as a continuous vari-
able was inversely associated with in-hospital mortality 
(for each 5 mmol/24 h decrease of UCE: OR 1.81, 95% CI 
1.66–1.97, P < 0.001; Table 2). This association remained 
significant (OR 1.49, 95% CI 1.34–1.65, P < 0.001), inde-
pendent of potential confounders (Table 2, model 5). 
Table 2 Logistic regression analyses of in‑hospital mortality
Multivariable logistic regression to assess the association of UCE with in-hospital mortality
a UCE was entered as a continuous variable per 5 mmol/24 h decrease
b Model 1: adjusted for sex in continuous analyses, no adjustment for sex-adjusted quintiles
c Model 2: adjusted as for model 1, additionally adjusted for age
d Model 3: adjusted as for model 2, additionally adjusted for kidney function (eGFR CKD–EPI)
e Model 4: adjusted as for model 3, additionally adjusted for body mass index (BMI)
f Model 5: adjusted as for model 4, additionally adjusted for severity of illness (APACHE-IV) and reason of admission (trauma vs non-trauma)
UCEa UCE sex‑stratified quintiles
(n = 6151) Q1 (n = 1228) Q2 (n = 1237) Q3 (n = 1208) Q4 (n = 1240) Q5 (n = 1238)
OR (95% CI) P OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) Reference
Model  1b 1.81 (1.66–1.97) < 0.001 4.34 (3.46–5.45) 2.24 (1.77–2.85) 1.58 (1.23–2.03) 1.32 (1.02–1.71) 1.00
Model  2c 1.67 (1.52–1.83) < 0.001 3.32 (2.61–4.20) 1.69 (1.32–2.17) 1.22 (0.94–1.59) 1.14 (0.88–1.48) 1.00
Model  3d 1.65 (1.51–1.81) < 0.001 3.21 (2.52–4.08) 1.68 (1.30–2.16) 1.24 (0.95–1.61) 1.15 (0.88–1.50) 1.00
Model  4e 1.70 (1.54–1.88) < 0.001 3.47 (2.69–4.49) 1.80 (1.38–2.33) 1.30 (0.99–1.70) 1.19 (0.91–1.55) 1.00
Model  5f 1.49 (1.34–1.65) < 0.001 2.56 (1.96–3.34) 1.45 (1.11–1.91) 1.09 (0.83–1.43) 1.08 (0.82–1.41) 1.00
Fig. 2 Short‑term and long‑term mortality as expressed in UCE quintiles. a In‑hospital mortality is depicted for the UCE quintiles in percentages. 
The first quintile represents the lowest UCE, the fifth quintile represents he highest quintile. Corresponding quintile cut‑off values are shown in 
Table 1. In‑hospital mortality increased when baseline UCE decreased (chi‑square test: P < 0.001). b Kaplan–Meier curves for 5 year survival (with 
95% CI) after hospital discharge. The colors of the quintiles correspond to colors as depicted in Fig. 2b. The highest UCE quintile had the best 5‑year 
survival, which declined with declining baseline UCE (log‑rank test: P < 0.001)
Because of the known sex difference in UCE, multivari-
able adjusted restricted cubic splines for the association 
of UCE with in-hospital mortality are shown separately 
for men and women in Fig. 3.
UCE and long‑term mortality
For the 5111 patients who were discharged alive from 
the hospital, long-term mortality was assessed. Over-
all 5-year mortality was 29%. In univariate analysis, 
UCE showed a strong relation with long-term survival 
as illustrated by the Kaplan–Meier curves (log-rank test 
P < 0.001, Fig. 2b). In Cox-regression with UCE expressed 
in quintiles, patients in the lowest UCE quintile had a 
four times higher risk for long-term mortality compared 
to those in the highest UCE quintile (HR 4.03, 95% CI 
3.35–4.84, P < 0.001, Table 3). After adjustment for poten-
tial confounders, this association remained independent 
(HR 2.32, 95% CI 1.89–2.85, P < 0.001, Table 3, model 5).
In Cox regression analysis with UCE expressed as a 
continuous variable, UCE was also associated with long-
term mortality (HR 1.76, 95% CI 1.66–1.88 for each 
5 mmol/d decrease of UCE, P < 0.001,Table 3). This asso-
ciation remained independent after adjustment for con-
founders with an HR of 1.49 (95% CI 1.38–1.62, P < 0.001, 
Table 3, model 5).
A multivariable adjusted restricted cubic spline for the 
association between UCE and mortality over 5 years for 
both men and women is shown in Fig. 4.
Subgroup, sensitivity and additional analyses
Additional subgroup and sensitivity analyses concerning 
the role of AKI, BMI and rhabdomyolysis amongst oth-
ers, are presented and shown in the SMF (Tables  ST1–
ST10, Figures SF1–SF12). We found similar associations 
between UCE and short-term and long-term mortality in 
both the subgroup and sensitivity analyses. The associa-
tion between UCE and short-term mortality was only not 
observed in trauma patients (OR 1.10, 95% CI 0.71–1.71, 
P = 0.69).
Discussion
This large prospective study shows that urinary creati-
nine excretion (UCE) early after ICU admission as a 
measure of muscle mass is strongly associated with both 
short-term and long-term mortality, independent of 
important covariates and confounders, including disease 
severity, age and renal function.
We consistently observed an inverse association 
between UCE and both short-term and long-term mor-
tality, even in patients with chronic kidney disease or 
AKI (Tables  ST1–ST10, Fig.  SF4). Only for short-term 
outcome in trauma patients, no independent associa-
tion with UCE was observed. However, a stronger asso-
ciation of UCE with long-term mortality was seen in 
the trauma patients when compared to the total patient 
group (Table ST4). As hospital mortality of severe trauma 
patients is mainly determined by age, severity of coma 
after trauma (and thus brain injury), base excess and 
Fig. 3 Association between UCE and in‑hospital mortality for both 
men and women. Data were fit by a multivariable logistic regression 
model based on restricted cubic splines. UCE was entered as continu‑
ous variable. Data were adjusted for sex, age, eGFR, BMI, severity of 
illness and reason of admission (model 5). Here, the median UCE was 
defined as the reference standard. The gray area represents the 95% 
CI. Here, the median UCE was defined as the reference standard. The 
curves in particular underscore the inverse relation of UCE with mor‑
tality for low and near median UCE values. Note the widely diverging 
95% CI at the extremes resulting from the low patient numbers and 
the cubic fit
coagulation disturbances [15], UCE is likely to be only 
a minor determinant of the short-term prognosis of 
trauma patients.
The relation of UCE with mortality has already been 
established in several other patient groups. A higher 
mortality in patients with low (baseline) UCE is present 
in renal transplant patients [16], patients with stroke [17], 
coronary artery disease [8], heart failure [18] and chronic 
kidney disease [19]. Moreover, a similar association is 
observed in the general population [10]. We are the first 
to examine the relationship of UCE with mortality in a 
large heterogenic critically ill patient group.
In several ICU subgroups, a J-shaped association 
between BMI and mortality was shown [20]. Other stud-
ies also show a beneficial effect of a moderately elevated 
BMI in several patient groups, including the critically ill 
[21–26]. It is very plausible that the increased mortal-
ity of patients with a low BMI results from the adverse 
effects of sarcopenia, as we found the highest mortality 
risk in patients in the lowest UCE quintile after adjust-
ment for BMI (Table ST6).
In patients without AKI, a decreased serum creatinine 
also is a reflection of muscle wasting [27] and two large 
studies showed that low baseline serum creatinine is an 
independent risk factor for mortality [27, 28]. Changes 
in serum creatinine, i.e. in AKI patients, seem only to 
be associated with short-term mortality [29]. Prognos-
tic ICU-models often incorporate serum creatinine 
as a measure of renal function [11, 30]. Although the 
APACHE-IV score also considers a lowered serum cre-
atinine level (< 53 µmol L−1 or < 0.6 mg dL−1) a mortal-
ity risk [11], no prognostic ICU-scoring system utilizes 
UCE as an outcome predictor. Both serum creatinine and 
UCE are influenced by renal insufficiency, but in steady-
state conditions, urinary excretion will equal creatinine 
production, irrespective of the serum creatinine concen-
tration. UCE will, therefore, better reflect muscle mass 
than serum creatinine, especially in patients with renal 
insufficiency. UCE determined early after ICU-admission 
might, therefore, improve prognostic ICU models and 
could be a significant contribution to the evolution of 
prognostic scores.
In our study we focused on UCE within 3 days of ICU 
admission and we did not focus on subsequent changes 
during ICU admission. In a recent study a decrease in 
UCE was seen after 7 and 14  days of ICU treatment, 
reflecting the gradual loss of muscle during ICU stay [31]. 
It seems plausible that a progressive decrease in UCE 
would further predict poor outcome, but this has to be 
assessed in future studies.
Although UCE presents a non-invasive and inexpensive 
method in ICU-patients, other methods of muscle mass 
estimation have been well researched in several patient 
populations; most are poorly suited for ICU patients [32–
37]. In the critically ill patient, anthropometric measure-
ments such as body weight, BMI, waist circumference 
or mid-arm or mid-thigh muscle area are often compli-
cated by the presence of dehydration, ascites or edema. 
More advanced techniques such as computed tomogra-
phy, magnetic resonance imaging or dual-energy X-ray 
absorptiometry are both expensive and impractical for 
routine use in the ICU [5]. Bioelectrical impedance anal-
ysis is a simple and non-invasive method that is widely 
used to obtain estimates of body composition [38], but its 
accuracy in detecting loss of muscle mass in ICU patients 
is questionable because its measurement requires fluid 
Table 3 Cox proportional hazard regression analyses for 5‑year mortality
Cox proportional hazard regression analysis to assess the association of UCE with 5-year survival
a UCE was entered as a continuous variable per 5 mmol/24 h decrease
b Model 1: adjusted for sex in continuous analyses, no adjustment for sex-adjusted quintiles
c Model 2: adjusted as for model 1, additionally adjusted for age
d Model 3: adjusted as for model 2, additionally adjusted for kidney function (eGFR CKD-EPI)
e Model 4: adjusted as for model 3, additionally adjusted for body mass index (BMI)
f Model 5: adjusted as for model 4, additionally adjusted for severity of illness (APACHE-IV) and reason of admission (trauma vs non-trauma)
UCEa UCE sex‑stratified quintiles
(n = 5111) Q1 (n = 850) Q2 (n = 1006) Q3 (n = 1040) Q4 (n = 1092) Q5 (n = 1123)
HR (95% CI) P HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) Reference
Model  1b 1.76 (1.66–1.88) < 0.001 4.03 (3.35–4.84) 3.02 (2.51–3.64) 2.36 (1.95–2.86) 1.65 (1.35–2.01) 1.00
Model  2c 1.56 (1.45–1.68) < 0.001 2.58 (2.13–3.13) 1.88 (1.55–2.28) 1.53 (1.26–1.87) 1.25 (1.02–1.53) 1.00
Model  3d 1.56 (1.45–1.67) < 0.001 2.59 (2.14–3.14) 1.87 (1.54–2.27) 1.52 (1.25–1.85) 1.24 (1.01–1.52) 1.00
Model  4e 1.56 (1.45–1.68) < 0.001 2.59 (2.12–3.17) 1.87 (1.53–2.29) 1.52 (1.24–1.85) 1.24 (1.01–1.51) 1.00
Model  5f 1.49 (1.38–1.62) < 0.001 2.32 (1.89–2.85) 1.71 (1.39–2.09) 1.39 (1.13–1.70) 1.17 (0.95–1.43) 1.00
homeostasis [39]. Repeated ultrasonography for the 
detection of muscle wasting shows promising results in 
a few relatively small studies [33–35], but muscle dimen-
sions are also influenced by generalized edema. In this 
regard, it would be interesting to compare UCE with both 
bioelectrical impedance and ultrasonography in a larger 
study population, while taking the fluid balance into 
account.
Some limitations of our study are due to its post hoc 
design and the long period it covers. An important poten-
tial limitation of UCE are the rapid changes in glomerular 
filtration rate as are common in the critically ill [40, 41]. 
UCE may decrease in patients with acute kidney injury, 
who have a higher risk of dying [30]. In some cases, UCE 
may increase because of augmented renal clearance, as 
has been reported in some younger trauma and sepsis 
patients [40]. Also, glomerular filtration may be altered 
by commonly administered drugs, such as vasopressors 
and diuretics [42, 43]. The differences in mortality could 
thus possibly be attributed to other factors such as renal 
function or hypercatabolism instead of muscle mass. We 
were unfortunately not able to address this as we did not 
perform true GFR measurements or other muscle mass 
measurements.
The relevance of decreased or increased glomerular 
filtration or creatinine clearance with respect to UCE 
could best be addressed by determining this parameter 
as well. We did adjust for eGFR as potential confounder; 
however, in the case of AKI it may take time before 
serum creatinine rises, limiting the value of this adjust-
ment. However, mean UCE did not significantly differ 
between days 1 and 3, and we excluded patients with 
severe AKI (stage 3). Furthermore, separate analyses per-
formed for both patients without and with AKI stage 1 or 
2 (SMF: Table ST3a, ST3b, Fig. SF4) led to similar find-
ings. Finally, we excluded patients with AKI stage 3, also 
because UCE cannot be determined in anuric patients. 
This is an obvious limitation of using this marker as a 
prognostic score. Estimation of muscle mass by measure-
ment of UCE also requires complete 24 h urine collection 
by ICU-nurses. Since ICU patients typically have indwell-
ing urine catheters, this was an advantage in our popula-
tion. In non-ICU patients who often have to collect the 
24-h urine themselves, it is therefore considered a less 
reliable method [4]. Creatinine levels in patients who 
are on an oral diet may also be increased by meat intake. 
In our study, this potential confounding factor was of 
no influence since all patients were on enteral or paren-
teral feeding containing no dietary meat. Our population 
consists of predominantly surgical rather than medical 
ICU patients. However, we saw similar findings in the 
population of non-surgical ICU patients (See SMF) and 
UCE was found to be a strong predictor of mortality in 
non-ICU medical patients as well [10, 17–19]. Recently, 
the sarcopenia index has been proposed as a measure 
for muscle mass [36, 37]. Although promising, we were 
unable to use this index as it requires cystatine C meas-
urement. Due to the retrospective nature of our study we 
were not able to compare UCE with other methods that 
estimate muscle mass, i.e. the paraspinal muscle surface 
area at lumbal vertebral levels measured on CT [5, 37]. 
However, future studies could assess the relationship 
between UCE and other muscle mass measures.
Fig. 4 Association between UCE and 5‑year survival for both men 
and women discharged alive. Data were fit by a Cox proportional 
hazard regression model based on restricted cubic splines. UCE was 
entered as continuous variable. Data were adjusted for sex, age, eGFR, 
BMI, severity of illness and reason of admission (model 5). The gray 
area represents the 95% CI
In conclusion, low urinary creatinine excretion early 
after ICU admission is a strong independent predictor 
of both short-term and long-term mortality after adjust-
ment for BMI, renal function and severity of disease, 
underscoring a role of muscle mass as risk factor for mor-
tality. UCE thus constitutes a simple, readily available and 
relevant prognostic biomarker for critically ill patients.
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